Infect Chemother.
2022 Jun;54(2):369-369. 10.3947/ic.2022.0040.
Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
- Affiliations
-
- 1Private Academic Consultant, Bangkok, Thailand
- 2Joseph Ayobabalola University, Ikeji- Arakeji, Nigeria
- 3Dr. D.Y. Patil University, Pune, India
- KMID: 2531029
- DOI: http://doi.org/10.3947/ic.2022.0040
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Erratum: Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
- Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
- Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
- The COVID-19 Correspondence Work Experience of Community Health Practitioners
- A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
